West Penn Allegheny Cancer Institute — Pittsburgh, Pennsylvania

West Penn Allegheny Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

West Penn Allegheny Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia.

Sponsors: Astex Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for West Penn Allegheny Cancer Institute?

West Penn Allegheny Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has West Penn Allegheny Cancer Institute conducted?

West Penn Allegheny Cancer Institute has 1 clinical trials on record. Their work covers Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia.

Is West Penn Allegheny Cancer Institute accredited by Crixeo Health?

West Penn Allegheny Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about West Penn Allegheny Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.